These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11778589)

  • 21. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 22. Is it ethical to keep interim findings of randomised controlled trials confidential?
    Miller FG; Wendler D
    J Med Ethics; 2008 Mar; 34(3):198-201. PubMed ID: 18316463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trial design issues: at least 10 things you should look for in clinical trials.
    Glasser SP; Howard G
    J Clin Pharmacol; 2006 Oct; 46(10):1106-15. PubMed ID: 16988199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Issues in evaluating health websites in an Internet-based randomized controlled trial.
    Eysenbach G
    J Med Internet Res; 2002 Dec; 4(3):E17. PubMed ID: 12554548
    [No Abstract]   [Full Text] [Related]  

  • 25. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
    Thorlund K; Devereaux PJ; Wetterslev J; Guyatt G; Ioannidis JP; Thabane L; Gluud LL; Als-Nielsen B; Gluud C
    Int J Epidemiol; 2009 Feb; 38(1):276-86. PubMed ID: 18824467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
    Whitehead A; Sooriyarachchi MR; Whitehead J; Bolland K
    Stat Med; 2008 May; 27(10):1646-66. PubMed ID: 17886243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Group sequential clinical trials for longitudinal data with analyses using summary statistics.
    Kittelson JM; Sharples K; Emerson SS
    Stat Med; 2005 Aug; 24(16):2457-75. PubMed ID: 15977295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?
    Bria E; Di Maio M; Cuppone F; Nisticò C; Cognetti F; Giannarelli D
    J Clin Oncol; 2007 Feb; 25(5):605-6; author reply 606-7. PubMed ID: 17290074
    [No Abstract]   [Full Text] [Related]  

  • 29. Communicating benefit and risk.
    Baglin T
    Br J Haematol; 2009 Jun; 146(1):31-3. PubMed ID: 19438473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression and randomized, controlled trials: problems and solutions.
    Hatcher S
    Expert Rev Neurother; 2006 Jan; 6(1):41-6. PubMed ID: 16466310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What we can learn from open-label extensions of randomized clinical trials.
    Cummings JL
    Arch Neurol; 2006 Jan; 63(1):18-9. PubMed ID: 16401732
    [No Abstract]   [Full Text] [Related]  

  • 33. Preliminary data release for randomized clinical trials of noninferiority: a new proposal.
    Korn EL; Hunsberger S; Freidlin B; Smith MA; Abrams JS
    J Clin Oncol; 2005 Aug; 23(24):5831-6. PubMed ID: 16027441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acupuncture trial with indistinguishable exposures is moot.
    Moffet H
    Clin Rehabil; 2008 Jan; 22(1):71; author reply 71-2. PubMed ID: 18089665
    [No Abstract]   [Full Text] [Related]  

  • 36. Ethical issues arising when interim data in clinical trials is restricted to independent data monitoring committees.
    Wells RJ; Gartside PS; McHenry CL
    IRB; 2000 Jan; 22(1):7-11. PubMed ID: 12546010
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized phase II trials with a prospective control.
    Jung SH
    Stat Med; 2008 Feb; 27(4):568-83. PubMed ID: 17573688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early average change in tumor size in a phase 2 trial: efficient endpoint or false promise?
    Rubinstein LV; Dancey JE; Korn EL; Smith MA; Wright JJ
    J Natl Cancer Inst; 2007 Oct; 99(19):1422-3. PubMed ID: 17895470
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomized control trials in ALS: lessons learned.
    Mitsumoto H; Gordon P; Kaufmann P; Gooch CL; Przedborski S; Rowland LP
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():8-13. PubMed ID: 15512861
    [No Abstract]   [Full Text] [Related]  

  • 40. Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections, by H. Schäfer and H.-H. Müller, Statistics in Medicine 2001; 20: 3741-3751.
    Bauer P; Posch M
    Stat Med; 2004 Apr; 23(8):1333-4; author reply 1334-5. PubMed ID: 15083486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.